GlobeNewswire 3/28/2022 Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance
TeleTrader 3/25/2022 Europe closes mostly higher after US, EU energy deal
GlobeNewswire 3/14/2022 Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire 3/1/2022 Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2/28/2022 Humacyte Announces Publication of Positive Long-Term Follow-Up Data from Phase 2 Trial of HAV™ for H...
GlobeNewswire 2/25/2022 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
GlobeNewswire 2/24/2022 OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results
GlobeNewswire 2/24/2022 Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
TeleTrader 2/22/2022 Europe closes mostly lower amid Ukraine worries
GlobeNewswire 2/3/2022 RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
GlobeNewswire 1/31/2022 Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to...
GlobeNewswire 1/28/2022 Humacyte Announces Preclinical Results of Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary ...
TeleTrader 1/25/2022 Europe shrugs off global turmoil, ends higher
TeleTrader 1/17/2022 Europe ends higher after upbeat Chinese data
TeleTrader 1/17/2022 Europe opens higher amid the Forum, COVID data
GlobeNewswire 1/5/2022 Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
GlobeNewswire 1/4/2022 Humacyte Announces Presentation of First Preclinical Results of the HAV™ in Coronary Artery Bypass G...
GlobeNewswire 12/31/2021 CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...
GlobeNewswire 12/15/2021 Humacyte Announces Publication Highlighting the First Use of the Human Acellular Vessel (HAV™) as Ar...
GlobeNewswire 12/9/2021 Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...
GlobeNewswire 11/22/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 11/22/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire 11/16/2021 Humacyte Presents Preclinical Results of Small-Diameter HAV™ for Use as a BTT Shunt in Pediatric Hea...
GlobeNewswire 11/15/2021 Humacyte Presents New 12-Month Data from HAVs™ Produced Using Commercial-Scale Manufacturing System
Newsfile Corp 11/15/2021 New Research Analysis Shows VINIA Reduces Oxidation Of LDL-Cholesterol To Support Cardiovascular Imp...
  • First page
  • Back
  • 1
  • 2
  • 3
  • 4
  • Next
  • Last page